Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Levi

Showing results (171-180 of 393) with videos related to

Pageof 40
Sort By:
Seminars in Thrombosis and Hemostasis|September 13, 2022
Disseminated Intravascular Coagulation: The Past, Present, and Future ConsiderationsToshiaki Iba, Marcel Levi, Jecko Thachil, et al.
The Lancet. Haematology|May 15, 2020
Coagulation abnormalities and thrombosis in patients with COVID-19Marcel Levi, Jecko Thachil, Toshiaki Iba, et al.
Eclinicalmedicine|February 7, 2022
Heatstroke-induced coagulopathy: Biomarkers, mechanistic insights, and patient managementToshiaki Iba, Jean Marie Connors, Marcel Levi, et al.
British Journal of Haematology|January 10, 2012
The withdrawal of Activated Protein C from the use in patients with severe sepsis and DIC [Amendment to the BCSH guideline on disseminated intravascular coagulation]Jecko Thachil, Cheng Hok Toh, Marcel Levi, et al.
Lancet (London, England)|February 5, 2016
Post-authorisation assessment of orphan drugsCarla E M Hollak, Marieke Biegstraaten, Marcel Levi, et al.
Hematology (Amsterdam, Netherlands)|February 18, 2004
Management of anticoagulant therapy for patients with prosthetic heart valves or atrial fibrillationRoel Vink, Renée B A Van Den Brink, Marcel Levi
Cardiovascular Research|February 6, 2002
Tissue factor and coronary artery diseaseArno H M Moons, Marcel Levi, Ron J G Peters
Current Opinion in Infectious Diseases|February 19, 2011
The effect of inflammation on coagulation and vice versaTom van der Poll, Johannes Daan de Boer, Marcel Levi
Allergy|November 30, 2018
Long-term effects upon rituximab treatment of acquired angioedema due to C1-inhibitor deficiencyMarcel Levi, Danny Cohn, Sacha Zeerleder, et al.
The New England Journal of Medicine|November 5, 2010
Safety of recombinant activated factor VII in randomized clinical trialsMarcel Levi, Jerrold H Levy, Henning Friis Andersen, et al.
Pageof 40

Showing results (171-180 of 393) with videos related to

Sort By:
Pageof 40
Seminars in Thrombosis and Hemostasis|September 13, 2022
Disseminated Intravascular Coagulation: The Past, Present, and Future ConsiderationsToshiaki Iba, Marcel Levi, Jecko Thachil, et al.
The Lancet. Haematology|May 15, 2020
Coagulation abnormalities and thrombosis in patients with COVID-19Marcel Levi, Jecko Thachil, Toshiaki Iba, et al.
Eclinicalmedicine|February 7, 2022
Heatstroke-induced coagulopathy: Biomarkers, mechanistic insights, and patient managementToshiaki Iba, Jean Marie Connors, Marcel Levi, et al.
British Journal of Haematology|January 10, 2012
The withdrawal of Activated Protein C from the use in patients with severe sepsis and DIC [Amendment to the BCSH guideline on disseminated intravascular coagulation]Jecko Thachil, Cheng Hok Toh, Marcel Levi, et al.
Lancet (London, England)|February 5, 2016
Post-authorisation assessment of orphan drugsCarla E M Hollak, Marieke Biegstraaten, Marcel Levi, et al.
Hematology (Amsterdam, Netherlands)|February 18, 2004
Management of anticoagulant therapy for patients with prosthetic heart valves or atrial fibrillationRoel Vink, Renée B A Van Den Brink, Marcel Levi
Cardiovascular Research|February 6, 2002
Tissue factor and coronary artery diseaseArno H M Moons, Marcel Levi, Ron J G Peters
Current Opinion in Infectious Diseases|February 19, 2011
The effect of inflammation on coagulation and vice versaTom van der Poll, Johannes Daan de Boer, Marcel Levi
Allergy|November 30, 2018
Long-term effects upon rituximab treatment of acquired angioedema due to C1-inhibitor deficiencyMarcel Levi, Danny Cohn, Sacha Zeerleder, et al.
The New England Journal of Medicine|November 5, 2010
Safety of recombinant activated factor VII in randomized clinical trialsMarcel Levi, Jerrold H Levy, Henning Friis Andersen, et al.
Pageof 40